Idexx Laboratories vs Medtronic
Idexx Laboratories (IDXX) and Medtronic (MDT) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $55B
- Last close
- $698.47
- 12 months
- +4.2%
- Market value
- $129B
- Last close
- $100.72
- 12 months
- −0.1%
At a glance
- By market value, Medtronic ($128.8B) is about 2.3 times Idexx Laboratories ($55.0B).
- Over the last 12 months Idexx Laboratories's share price moved +4.2% and Medtronic's −0.1%; against the S&P 500 that is −6.4 points and −10.7 points.
- In their last fiscal years Idexx Laboratories kept 24.6% of revenue as net income and Medtronic 13.2%.
- In the last 90 days insiders reported 0 open-market purchases at Idexx Laboratories and 0 at Medtronic; members of Congress disclosed 0 trades in Idexx Laboratories and 1 in Medtronic.
- Next results: Idexx Laboratories Feb 1, 2027, Medtronic Nov 24, 2026.
Share price over the last 12 months
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| Idexx Laboratories IDXXNASDAQ · Health Care Equipment | Medtronic MDTNYSE · Health Care Equipment | |
|---|---|---|
| Size and profitability | ||
| Market value | $55B | $129B |
| Revenue, last fiscal year | $4.3B | $36.4B |
| Net income, last fiscal year | $1.06B | $4.8B |
| Net marginNet income as a share of revenue | 24.6% | 13.2% |
| Free cash flow | $1.06B | |
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Compare with another company
Idexx Laboratories against
Common questions
How is Idexx Laboratories different from Medtronic?
Idexx Laboratories (IDXX) is in Health Care Equipment on NASDAQ, with $4.3B of revenue in its last fiscal year and a net margin of 24.6%. Medtronic (MDT) is in Health Care Equipment on NYSE, with $36.4B of revenue in its last fiscal year and a net margin of 13.2%. Both are in the same industry, so the gap is mostly one of size and profitability. The table above sets their figures side by side; it compares filings and is not a view on either stock.
How do Idexx Laboratories and Medtronic compare in size?
Medtronic has the larger market value: Idexx Laboratories $55B and Medtronic $129B, at the last close.
Whose share price rose more over the last 12 months, IDXX or MDT?
Over the last 12 months Idexx Laboratories moved +4.2% and Medtronic −0.1%. Past price moves say nothing about the future.
Which has had more insider buying, Idexx Laboratories or Medtronic?
Since 2006, Idexx Laboratories insiders reported 24 open-market purchases against 13 for Medtronic. These are counts of what was filed, not a view on either stock.
Do members of Congress trade IDXX or MDT?
In the last 12 months, members of Congress disclosed 2 trades in Idexx Laboratories (IDXX) and 9 in Medtronic (MDT).
When did insiders last buy IDXX and MDT?
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Idexx Laboratories pageMedtronic pageRare insider trades this weekAll comparisons
https://oqro.io/compare/idxx-vs-mdt







